Search

What you need to know about recent advances in genetics of hearing loss in the newborn

Identifying the underlying genetic cause of hearing loss in newborns can improve dramatically the early diagnosis and appropriate intervention. Hearing loss is the most common sensory disorder at birth, affecting approximately two out of 1000 newborns [1]. Congenital impaired hearing...

Chronic rhinosinusitis management: back to the future?

Immunology is a dim and distant medical school memory to many ENT surgeons, but the increasingly complex immunology of chronic rhinosinusitis is fascinating (honestly!). Medical management options in CRS no longer just involves saline and steroids, and we need to...

Clinical leadership and management: the ‘Darzi’ experience

The Fellowship in Clinical Leadership programme, more commonly known as the ‘Darzi Fellowship,’ commenced in 2009. It was designed to provide junior doctors at the registrar level with postgraduate training in clinical leadership and change management in order to develop...

Lessons learned from running a national thyroid surgery registry

The UK Registry of Endocrine and Thyroid Surgery is now yielding the rewards of meticulous data collection and years of hard work. David Scott-Coombes discusses the advantages and the unintended consequences of their success. The British Association of Endocrine and...

Musical perception and the brain: In conversation with Charles Limb

One of the unique aspects of BACO 2020 will be a public engagement event. Charles Limb, an esteemed guest lecturer from San Francisco, will delve deep into the neurological experience of music. Who better than our very own Declan Costello...

Head and neck cancer multidisciplinary team

Why do we have MDTs? Do they make a difference to outcomes? Jon Bernstein explores the whys and wherefores of the head and neck cancer MDT, and wonders where things might go from here… Head and neck (upper aerodigestive tract)...

Otology training in low- and middle-income countries: a view from within

It is recognised that hearing loss and ear disease are far more common in less affluent parts of the world, and that those countries are often least able to provide treatment; so how can we prioritise care for these patients?...

Help shape the future of mild to moderate hearing loss research

A James Lind Alliance Priority Setting Partnership has been formed to help shape the future of research into mild-moderate hearing loss. Who is the Priority Setting Partnership? The Partnership brings together Hearing Link, Action on Hearing Loss, the British Society...